Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Future directions for antifolate drug development.

C B Knight¹, P C Elwood, B A Chabner

¹Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892.

Advances in Enzyme Regulation

|January 1, 1989

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cytidine and deoxycytidylate deaminase inhibition by uridine analogs.

Biochemical pharmacology·2010

Same author

Complementary, alternative, integrative, or unconventional medicine?

The oncologist·2001

Same author

The oncologic four-minute mile.

The oncologist·2001

Same author

Losing God.

The oncologist·2001

Same author

Caring for colleagues.

The oncologist·2001

Same author

Medical mistakes: a workshop on personal perspectives.

The oncologist·2001

Same journal

The role of inositol polyphosphate 4-phosphatase 1 in platelet function using a weeble mouse model.

Advances in enzyme regulation·2010

Same journal

RAS oncogene-mediated deregulation of the transcriptome: from molecular signature to function.

Advances in enzyme regulation·2010

Same journal

Temporal and functional analysis of DNA replicated in early S phase.

Advances in enzyme regulation·2010

Same journal

Genetic ablation of S6-kinase does not prevent processing of SREBP1.

Advances in enzyme regulation·2010

Same journal

Advances in Enzyme Regulation. Foreword.

Advances in enzyme regulation·2010

Same journal

Sphingosine kinase localization in the control of sphingolipid metabolism.

Advances in enzyme regulation·2010

See all related articles

New antifolate drugs can be designed to inhibit sensitive and resistant tumors. Strategies include targeting alternative enzymes and enhancing drug accumulation within cells for improved cancer treatment.

Area of Science:

Biochemistry
Pharmacology
Oncology

Background:

Antifolates are crucial in cancer chemotherapy.
Drug resistance limits antifolate efficacy.
Understanding folate metabolism is key to overcoming resistance.

Purpose of the Study:

To explore novel antifolate drug design strategies.
To identify methods for overcoming antifolate resistance.
To enhance the therapeutic potential of antifolates.

Main Methods:

Discussion of potential antifolate drug design approaches.
Analysis of targeting alternative folate-dependent enzymes.
Investigation of intracellular accumulation and polyglutamation.

Related Experiment Videos

Main Results:

New antifolates can be designed for sensitive and resistant cell inhibition.
Targeting alternative enzymes and increasing intracellular antifolate levels are viable strategies.
Antibodies and cDNAs of transport proteins aid resistance understanding.

Conclusions:

Optimizing antifolate transport and polyglutamation can overcome resistance.
Characterizing folate transport proteins is crucial for new drug development.
Novel antifolate therapies hold promise for resistant cancers.